EDWARD KLEPPER: Open Payments
NPI 1063053502 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 48 payments from 12 companies in 2025. Trend: 2023 $1,463 · 2024 $1,102 · 2025 $1,373
Food & beverage: $1,175Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $303 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $256 |
| UCB, Inc. | 13 | $203 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Arcutis Biotherapeutics, Inc. | 1 | $119 |
| Organon LLC | 6 | $116 |
| ABBVIE INC. | 3 | $75 |
| Galderma Laboratories, L.P. | 2 | $56 |
| LEO Pharma Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: TREMFYA, Bimzelx, ILUMYA, Zoryve, COSENTYX, RINVOQ, Rhapsido, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
